Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Evolva Holding SA

+ Add to Watchlist

EVE:SW

1.69 CHF 0.02 1.20%

As of 06:21:34 ET on 03/03/2015.

Snapshot for Evolva Holding SA (EVE)

Open: 1.66 Day's Range: 1.64 - 1.72 Volume: 4,777,317
Previous Close: 1.67 52wk Range: 1.07 - 1.72 1-Yr Rtn: +19.01%

Stock Chart for EVE

No chart data available.
  • EVE:SW 1.69
  • 1D
  • 1M
  • 1Y
1.67
Interactive EVE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for EVE

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SMI -
Earnings Per Share (CHF) (ttm) -0.0700
Est. EPS (CHF) (12/2014) -0.0680
Est. PEG Ratio -
Market Cap (M CHF) 556.87
Shares Outstanding (M) 327.57
30 Day Average Volume 1,837,603
Price/Book (mrq) 4.0868
Price/Sale (ttm) 40.8659
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for EVE

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for EVE

Evolva Holding SA is a biotech firm. The Company's mission is to discover and provide innovative, sustainable ingredients for health, nutrition and wellness. Evolva uses biosynthetic and evolutionary technologies to create and optimise small molecule compounds and their production routes.

Neil GoldsmithCEO/Managing DirectorJakob Dynnes HansenChief Financial Officer
Jorgen HansenChief Scientific OfficerPascal LongchampChief Business Officer
More Company Profile & Key Executives for EVE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil